Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceanti-neoplastic agent, cytokine reaction, hypersensitivity, infusion reaction, m
Choose Specialty Biosimilars Brain Cancer Breast CancerBreast Cancer CAR T-cell Therapy COVID-19 Disparities in Cancer Care Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer Genitourinary CancersGenitourinary CancersGenitourinary Cancers Global Oncology ...
医学 两周一更 The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is ...
0.3%-1.2%), compared with a 0.37% cumulative incidence in Wuhan, China, over the same time period.4In a separate retrospective cohort study that included 18 patients with cancer who had COVID-19 (of 1590 total patients with
Cost: Intravenous cyclophosphamide is more expensive than oral and requires the availability of an infusion suite and experienced staff. • Convenience: Oral cyclophosphamide does not require patients to come to the healthcare facility for regular drug infusions but results in rapid increase in cumula...
In 2009, the Department of Clinical Pharmacy was implemented in teaching at the hospital of the Jordan University of Science and Technology (JUST) in an effort to provide health care services. Also, in the same year the King Hussein Cancer Center (KHCC) in Amman fully implemented a clinical ...
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial Lacey J. Padrón, Deena M. Maurer, Mark H. O’Hara, Eileen M. O’Reilly, Robert A. Wolff, Zev A. Wainberg, Andrew...
consideredexplainedif the measurements coincided with a dilutional explanation (e.g. saline infusion, chemo-infusion), acute illness potentially explaining (e.g. gastroenteritis with vomiting and diarrhea), dietary restriction, medication with known side effect (e.g. Bortezomib, amphotericin B), or...
Cancer Therapy Cancer therapeutic resistance PubMedGoogle Scholar N. Engl. J. Med.362, 1605–1617 (2010). ArticleCASPubMedGoogle Scholar Rahib, L.et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.Cancer Re...
This phase I study investigated the maximum tolerated dose (MTD), safety, pharmacokinetics and antitumor activity of ganetespib in patients with solid malignancies. Methods Patients were enrolled in cohorts of escalating ganetespib doses, given as 1 hour IV infusion, once weekly for 3 weeks, follow...